"Uw vertrouwde ziekenhuis in Utrecht"

During the past decade, Diakonessenhuis conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 6 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 3 clinical trials were completed. i.e. 10.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakonessenhuis" #1 sponsor was "UMC Utrecht" with 11 trials, followed by "Maastricht University Medical Center" with 6 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 5 trials sponsored, "The Netherlands Cancer Institute" with 5 trials sponsored and "Diakonessenhuis, Utrecht" with 5 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonessenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 12 trials as a collaborator, "Borstkanker Onderzoek Groep" with 4 trials as a collaborator, "Diakonessenhuis, Utrecht" with 4 trials as a collaborator, "Dutch Cancer Society" with 4 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Diakonessenhuis" are "Breast Cancer" (5 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Neoplasms" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Diakonessenhuis" in a lesser frequency.

Most popular intervention types in "Diakonessenhuis" are "Drug" (35 trials), "Other" (16 trials), "Procedure" (14 trials), "Device" (7 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Capecitabine" (2 trials), "Flucloxacillin" (2 trials), "Fulvestrant" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Diakonessenhuis" are 69 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 34 active trials in "Diakonessenhuis". 1 are not yet recruiting, 17 are recruiting, 12 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 31 completed trials in Diakonessenhuis, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Diakonessenhuis, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".